Cargando…
TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed
The wound healing process initiates after injury to a tissue and involves a series of orchestrated events to minimize the invasion of foreign matters such as bacteria and efficiently regenerate the damaged tissue. A variety of cells must be recruited to the tissue during wound healing. However, this...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378794/ https://www.ncbi.nlm.nih.gov/pubmed/28421182 http://dx.doi.org/10.3389/fcell.2017.00028 |
_version_ | 1782519480863162368 |
---|---|
author | Ghosh, Deepraj McGrail, Daniel J. Dawson, Michelle R. |
author_facet | Ghosh, Deepraj McGrail, Daniel J. Dawson, Michelle R. |
author_sort | Ghosh, Deepraj |
collection | PubMed |
description | The wound healing process initiates after injury to a tissue and involves a series of orchestrated events to minimize the invasion of foreign matters such as bacteria and efficiently regenerate the damaged tissue. A variety of cells must be recruited to the tissue during wound healing. However, this process is severely disrupted in patients suffering from chronic illness, including diabetes, leading to impaired healing or non-healing wounds. Current avenues of treatment include negative-pressure therapy, wound debridement, growth factor replacement, and cell-based therapies. Among these therapies, mesenchymal stem cells (MSCs) delivery to the wound holds a very high promise due to the innate abilities of MSCs that include immunogenicity, plasticity, and self-renewal. Bone marrow derived MSCs have been shown to promote more rapid wound healing by increased cytokine production in diabetic mice. However, the lack of understanding of the mechanical and chemical interaction of the transplanted MSCs with the factors present in the regenerative niches limits their efficacy in the wound bed. In this study, we sought to understand how the changes in MSC biochemical and biophysical properties can affect their function in vitro and in vivo. We demonstrate that pretreatment of MSCs with the mechano-stimulatory soluble factor transforming growth factor (TGF-β1), which is highly expressed in injury sites, improves wound closure in a syngeneic murine wound model. This improved wound closure correlated with increased invasion into the wound bed. In vitro studies demonstrated that TGF-β1 pretreatment expedited wound closure by increasing adhesion, traction force, and migration even after removal of the stimulus. Furthermore, this response was mediated by the cytoskeletal protein focal adhesion kinase. Taken together, this study suggests that defined chemical stimuli can benefit site specific adaptability of MSCs to improve their function and therapeutic usefulness. |
format | Online Article Text |
id | pubmed-5378794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53787942017-04-18 TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed Ghosh, Deepraj McGrail, Daniel J. Dawson, Michelle R. Front Cell Dev Biol Cell and Developmental Biology The wound healing process initiates after injury to a tissue and involves a series of orchestrated events to minimize the invasion of foreign matters such as bacteria and efficiently regenerate the damaged tissue. A variety of cells must be recruited to the tissue during wound healing. However, this process is severely disrupted in patients suffering from chronic illness, including diabetes, leading to impaired healing or non-healing wounds. Current avenues of treatment include negative-pressure therapy, wound debridement, growth factor replacement, and cell-based therapies. Among these therapies, mesenchymal stem cells (MSCs) delivery to the wound holds a very high promise due to the innate abilities of MSCs that include immunogenicity, plasticity, and self-renewal. Bone marrow derived MSCs have been shown to promote more rapid wound healing by increased cytokine production in diabetic mice. However, the lack of understanding of the mechanical and chemical interaction of the transplanted MSCs with the factors present in the regenerative niches limits their efficacy in the wound bed. In this study, we sought to understand how the changes in MSC biochemical and biophysical properties can affect their function in vitro and in vivo. We demonstrate that pretreatment of MSCs with the mechano-stimulatory soluble factor transforming growth factor (TGF-β1), which is highly expressed in injury sites, improves wound closure in a syngeneic murine wound model. This improved wound closure correlated with increased invasion into the wound bed. In vitro studies demonstrated that TGF-β1 pretreatment expedited wound closure by increasing adhesion, traction force, and migration even after removal of the stimulus. Furthermore, this response was mediated by the cytoskeletal protein focal adhesion kinase. Taken together, this study suggests that defined chemical stimuli can benefit site specific adaptability of MSCs to improve their function and therapeutic usefulness. Frontiers Media S.A. 2017-04-04 /pmc/articles/PMC5378794/ /pubmed/28421182 http://dx.doi.org/10.3389/fcell.2017.00028 Text en Copyright © 2017 Ghosh, McGrail and Dawson. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Ghosh, Deepraj McGrail, Daniel J. Dawson, Michelle R. TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed |
title | TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed |
title_full | TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed |
title_fullStr | TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed |
title_full_unstemmed | TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed |
title_short | TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed |
title_sort | tgf-β1 pretreatment improves the function of mesenchymal stem cells in the wound bed |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378794/ https://www.ncbi.nlm.nih.gov/pubmed/28421182 http://dx.doi.org/10.3389/fcell.2017.00028 |
work_keys_str_mv | AT ghoshdeepraj tgfb1pretreatmentimprovesthefunctionofmesenchymalstemcellsinthewoundbed AT mcgraildanielj tgfb1pretreatmentimprovesthefunctionofmesenchymalstemcellsinthewoundbed AT dawsonmicheller tgfb1pretreatmentimprovesthefunctionofmesenchymalstemcellsinthewoundbed |